Cary, NC, United States of America

Rajendra Uprety

USPTO Granted Patents = 3 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Rajendra Uprety

Introduction

Rajendra Uprety is a notable inventor based in Cary, NC (US), recognized for his significant contributions to the field of pharmaceutical sciences. With a total of three patents to his name, Uprety has made strides in developing compounds that target specific health conditions.

Latest Patents

Among his latest patents, Uprety has developed substituted alkylphenols as HCN1 antagonists. These compounds, which include those of Formula (I) and Formula (II), are designed to modulate HCN channels, which are nonselective voltage-gated cation channels found in the plasma membranes of heart and brain cells. The patents also detail pharmaceutical compositions and kits that incorporate these compounds, along with methods for treating HCN-related disorders, such as pain, by administering the described compounds and compositions.

Career Highlights

Uprety has had a distinguished career, working at esteemed institutions such as Cornell University and the University of Health Sciences & Pharmacy in St. Louis. His work has focused on advancing the understanding and treatment of various medical conditions through innovative pharmaceutical solutions.

Collaborations

Uprety has collaborated with notable colleagues, including Gareth R. Tibbs and Peter A. Goldstein, contributing to a rich exchange of ideas and advancements in their respective fields.

Conclusion

Rajendra Uprety's innovative work in developing pharmaceutical compounds showcases his commitment to improving health outcomes. His contributions continue to influence the field of medical science and highlight the importance of research and innovation in addressing health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…